SAINTRY SUR SEINE, France

Célia Roussel

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Abolis Biotechnologies, Les Laboratoires Servier. Active years: 2024-2025.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Célia Roussel: Innovator in Biosynthesis

Introduction

Célia Roussel is a notable inventor based in Saintry sur Seine, France. He has made significant contributions to the field of biotechnology, particularly in the biosynthesis of flavonoids. With a total of 2 patents, Roussel's work focuses on the development of recombinant microorganisms for the production of valuable compounds.

Latest Patents

Roussel's latest patents include a method for biosynthesizing diosmetin and/or hesperetin in a microorganism. This invention relates to a recombinant microorganism modified to produce diosmetin and/or hesperetin, which can be utilized for various applications. Another significant patent is for the biosynthesis of diosmin and/or hesperidin in a microorganism. This invention also involves a recombinant microorganism capable of producing diosmin and hesperidin, highlighting Roussel's innovative approach to biotechnology.

Career Highlights

Throughout his career, Célia Roussel has worked with prominent companies in the biotechnology sector. Notable among these are Abolis Biotechnologies and Les Laboratoires Servier. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative research.

Collaborations

Roussel has collaborated with several professionals in his field, including Cyrille Pauthenier and Hélène Scornec. These collaborations have likely enhanced his research and development efforts, leading to his successful patent applications.

Conclusion

Célia Roussel is a distinguished inventor whose work in biosynthesis has the potential to impact various industries. His innovative patents and collaborations reflect his commitment to advancing biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…